Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study-Reference-Cited by-同舟云学术

Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study

Published:2022-07-20 Issue:14 Volume:135 Page:1762-1764
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Zhang Jinru,Chen Juping,Li Jia,Li Jian,Miao Hong,Zhu Xiangyang,Meng Meng,Han Yang,Chen Jing,Cheng Xiaoyu,Xiong Kangping,Jin Hong,Luo Weifeng,Mao Chengjie,Liu Chunfeng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference14 articles.

1. Fatigue correlates with sleep disturbances in Parkinson disease;Cao;Chin Med J,2020

2. Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment;Fabbrini;Neurol Sci,2003

3. Selegiline in the treatment of daily fluctuations in disability of parkinsonian patients with long-term levodopa treatment;Heinonen;Acta Neurol Scand Suppl,1989

4. A randomized double-blind placebo-controlled phase III trial of selegiline monotherapy for early Parkinson disease;Mizuno;Clin Neuropharmacol,2017

5. Selegiline in the treatment of narcolepsy;Hublin;Neurology,1994

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Landscape of Alertness-Enhancing Drugs: A Contemporary Review;International Journal of Advanced Research in Science, Communication and Technology;2024-01-31

2. Medical, surgical, and physical treatments for Parkinson's disease;The Lancet;2024-01

3. Daytime sleepiness in Parkinson's disease: a multifaceted symptom;Frontiers in Sleep;2023-12-22